Sanjiv Sam Gambhir Selected Research

Sanjiv Sam Gambhir Research Topics

Disease

67	Neoplasms (Cancer) 12/2022 - 11/2005
9	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 11/2005
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2012
7	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2003
6	Melanoma (Melanoma, Malignant) 12/2017 - 05/2007
5	Neoplasm Metastasis (Metastasis) 12/2022 - 04/2003
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2015 - 11/2008
4	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 12/2008
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2011 - 03/2004
3	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2012
3	Lymphoma (Lymphomas) 12/2012 - 03/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 03/2022 - 12/2008
2	Atherosclerotic Plaque (Atheroma) 09/2021 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2018
2	Hypoxia (Hypoxemia) 01/2018 - 07/2007
2	Myocardial Infarction 06/2015 - 04/2008
2	Hyperglycemia 05/2011 - 07/2006
2	Squamous Cell Carcinoma of Head and Neck 04/2011 - 04/2010
1	Lymphatic Metastasis 12/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Glioma (Gliomas) 12/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hyperthermia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Bacterial Infections (Bacterial Infection) 10/2017
1	Adenocarcinoma 10/2017

Drug/Important Bio-Agent (IBA)

16	Peptides (Polypeptides)IBA 12/2022 - 11/2005
13	IntegrinsIBA 12/2022 - 11/2005
11	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 03/2004
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2007
7	Cystine (L-Cystine)IBA 12/2022 - 02/2010
7	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2011
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017 - 12/2008
5	RadiopharmaceuticalsIBA 12/2022 - 04/2003
5	Cystine-Knot MiniproteinsIBA 12/2022 - 03/2009
5	diazobenzenesulfonic acid (DASA)IBA 12/2021 - 10/2015
5	arginyl-glycyl-aspartic acidIBA 11/2015 - 11/2005
4	Pyruvate KinaseIBA 12/2021 - 10/2015
4	Contrast MediaIBA 01/2021 - 06/2010
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2008
4	aspartic acid glycine arginineIBA 11/2015 - 04/2013
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2015 - 05/2007
4	Molecular Probes (Molecular Probe)IBA 06/2010 - 05/2007
3	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 05/2008
3	Rituximab (Mabthera)FDA Link 08/2015 - 12/2013
3	LuciferasesIBA 01/2013 - 04/2007
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 12/2019
2	Carbon Nanotubes (Carbon Nanotube)IBA 09/2021 - 04/2013
2	LigandsIBA 12/2017 - 04/2013
2	EnzymesIBA 01/2017 - 03/2013
2	Technetium Tc 99m MedronateIBA 12/2015 - 07/2013
2	FluorineIBA 11/2015 - 11/2014
2	Streptozocin (Streptozotocin)FDA Link 06/2015 - 05/2011
2	64Cu-DOTA-rituximabIBA 01/2015 - 10/2012
2	AcidsIBA 01/2015 - 03/2009
2	AntigensIBA 04/2014 - 03/2012
2	Thymidine KinaseIBA 05/2011 - 07/2007
2	PeptidomimeticsIBA 02/2010 - 12/2009
2	CY5.5 cyanine dyeIBA 03/2009 - 05/2006
2	Renilla LuciferasesIBA 01/2008 - 07/2007
2	Type 1 Melanocortin ReceptorIBA 06/2007 - 05/2007
2	alpha-MSHIBA 06/2007 - 05/2007
2	Fluorescent Dyes (Fluorescent Probes)IBA 05/2006 - 11/2005
1	SodiumIBA 03/2022
1	MicroRNAs (MicroRNA)IBA 03/2022
1	Therapeutic UsesIBA 03/2022
1	Chelating AgentsIBA 01/2021
1	GastrinsIBA 01/2021
1	CopperIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Circulating Tumor DNAIBA 12/2020
1	CarbonIBA 01/2020
1	Gallium-68IBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019
1	TalinIBA 01/2019
1	olaparibIBA 01/2018
1	Peroxiredoxin VIIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	pembrolizumabIBA 12/2017
1	PiperazineIBA 10/2017
1	maltodextrinIBA 10/2017

Therapy/Procedure

29	Therapeutics 03/2022 - 04/2003
4	Precision Medicine 01/2018 - 05/2016
3	Radioimmunotherapy 04/2010 - 03/2008
3	Islets of Langerhans Transplantation 12/2006 - 03/2004
2	Aftercare (After-Treatment) 03/2022 - 09/2008
2	Immunotherapy 01/2020 - 04/2010
2	Drug Therapy (Chemotherapy) 02/2012 - 09/2008
2	Quantum Dots (Quantum Dot) 10/2010 - 09/2008
1	Complementary Therapies (Alternative Medicine) 03/2022
1	Intravenous Injections 09/2021
1	Transplantation 01/2020
1	Cell Transplantation 01/2017